Tokyo, Nov. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059698) titled 'Observation of the therapeutic effects of rehabilitation and lidocaine injections on postural abnormalities in Parkinson's disease and related disorders' on Nov. 8.
Study Type:
Observational
Primary Sponsor:
Institute - National Research and Development Agency
Condition:
Condition - Parkinson's disease and related disorders
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to investigate the therapeutic effects of rehabilitation and lidocaine injections performed at NCNP on postural abnormalities in Parkinson's disease and related diseases.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Patients of Parkinson's disease-related disorders with postural abnormalities
2) Patients who have received or will receive treatment for postural abnormalities at our hospital
3) Those who are able to maintain a standing position
4) Those who have received an explanation of this study, understood its purpose, and agreed to participate
5) Those who have been treated for postural abnormalities for more than 6 months
Key exclusion criteria - 1) Those who cannot maintain an upright position
2) Others who the principal investigator deems inappropriate
Target Size - 180
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2023 Year 03 Month 13 Day
Date of IRB - 2023 Year 03 Month 22 Day
Anticipated trial start date - 2023 Year 03 Month 22 Day
Last follow-up date - 2028 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062978
Disclaimer: Curated by HT Syndication.
